Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 19, 2002 - Issue 3
Submit an article Journal homepage
16
Views
0
CrossRef citations to date
0
Altmetric
Research Article

PAUCITY OF HEMATOLOGICAL NEOPLASIA AFTER TREATMENT OF HODGKIN DISEASE: Observation After Long-Term Follow-Up at Cancer Institute, Chennai, South India

T. G. Sagar Cancer Institute (WIA), Chennai, India
,
Anita Chandra Cancer Institute (WIA), Chennai, India
,
S. G. Raman Cancer Institute (WIA), Chennai, India
&
R. Swaminathan Cancer Institute (WIA), Chennai, India
Pages 197-203 | Published online: 09 Jul 2009

  • Pedersen BJ, Larsen SO, Struct J, et al. Risk of therapy related leukemia and preleukemia after Hodgkin's disease. Lancet. 1987;2:83-88.
  • Kaldor JM, Day NE, Clarke EA, et al. Leukemia following Hodgkin's disease. N Engl J Med. 1990; 322:7-13.
  • van Leeuwen FE, Charus AMJ, van den Belot-Dusebout AW, et al. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkalyting agents, treatment with teniposide combination, number of episodes of chemotherapy and bone marrow damage. J Clin OncoL 1994;12:1063-1073.
  • Henry Amar M, Pellae-Cosset B, Bayle-Weisgerber C, et al. Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: the Institute Gustava Roussy experience: recent results. Cancer Ass. 1989;117:270-283.
  • Tucker MA, Goleman CN, Cox RS, et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 1988;318:76-81.
  • Hoppe RT. Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease. Leukemia. 1992;Suppl 6:155-157.
  • van Leeuwen FE, Klokman WJ, Hagenbeck A, et al. Second cancer risk following Hodgkin's disease: a 20-year follow up study. J Clin Oncol. 1994;12:312.
  • Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996;334:745-757.
  • Devita VT, Simon RM, Hubard SM, et al. Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow up of MOPP treated patients at the National Cancer Institute. Ann Intern Med. 1980;92:587-595.
  • Bonadonna G, Zucali R, Monfardini S, et al. Combination chemotherapy of Hodgkin's diseasewith Adriamycin, bleomycin, vinblastine and imidazole carboxamide versus MOPP. Cancer. 1975;36: 252-259.
  • Bonadona G, Valagussa P, Santoro A. Alternating of non-cross resistant combination chemotherapy of MOPP in stage IV Hodgkin's disease: a report of 8 year results. Ann Intern Med. 1986;104: 739-746.
  • Somers R, Carde P, Henry AM, et al. A randomized study in stage III B and IV Hodgkin's disease comparing eight courses of MOPP versus an alternating MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie Curie controlled clinical trial. Oncology. 1994;12:279-287.
  • Klimo P, Connors JM. MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease. J Clin Oncol. 1985;3:1174-1182.
  • Klimo P, Connors JM. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with MOPP/ABV hybrid program. Semin Hematol. 1988;25(Suppl 2): 34-40.
  • Kaplan GL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:57-63.
  • Meadows AT, Obringer AC., Marrero O, et al. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. Med Pediatr Oncol. 1989;17:477-484.
  • Valagussa P, Santoro A, Rendra R, et al. Second malignancies in Hodgkin's disease: a complication of certain forms of treatment. BMJ. 1990;280:216-219.
  • Jenkin D, Greenberg M, Fitzgerald A. Second malignant tumours in childhood Hodgkin's disease. Med Pediatr Oncol. 1996;26:373-379.
  • Schellong G, Riepenhausen M, Creutzig Y et al. Low risk of secondary leukemia after chemotherapy without mechlorethamine in childhood Hodgkin's disease. J Clin Oncol. 1997;15:2247-2253.
  • Tura S, Fiacchini M, Zinzani PL, et al. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol 1993;11:925-930.
  • Buyukpamkur M, Ataham L, Laglar M, et al. Hodgkin's disease in Turkish children: clinical characteristics and treatment results of 210 patients. Pediatr Hematol Oncol 1999;16:199-229.
  • Montoto S, Camos M, Lopez-Guillermo A, et al. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisolone, doxorubicin, bleomycin and vinblastine (C-MOPP/ ABV) as first line treatment for patients with advanced Hodgkin's disease. Cancer. 2000;88:2142-2148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.